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Abstract
Antibody-dependent enhancement (ADE) of virus infection caused by the uptake of virus-antibody complexes by FccRs is a
significant obstacle to the development of effective vaccines to control certain human and animal viral diseases. The
activation FccRs, including FccRI and FccRIIa have been shown to mediate ADE infection of virus. In the present paper, we
showed that pocine FccRIIb, an inhibitory FccR, mediates ADE of PRRSV infection. Stable Marc-145 cell lines expressing
poFccRIIb (Marc-poFccRII) were established. The relative yield of progeny virus was significantly increased in the presence of
sub-neutralization anti-PRRSV antibody. The Fab fragment and normal porcine sera had no effect. Anti-poFccRII antibody
inhibited the enhancement of infection when cells were infected in the presence of anti-PRRSV antibody, but not when cells
were infected in the absence of antibody. These results indicate that enhancement of infection in these cells by anti-PRRSV
virus antibody is FccRII-mediated. Identification of the inhibitory FccR mediating ADE infection should expand our
understanding of the mechanisms of pathogenesis for a broad range of infectious diseases and may open many approaches
for improvements to the treatment and prevention of such diseases.
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Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV) is
an enveloped positive-strand RNA virus in the family Arteriviridae [1].
PRRS can cause severereproductive failure insows and is associated
with the porcine respiratory disease complex in combination with
secondary infection [2–4]. The virus is present in a majority of swine
producing countries around the world and gives rise to significant
economic losses in pig farming [5]. Swine are the only known host of
PRRSV, and myeloid cells, particularly macrophages and dendritic
cells, are the primary permissive cells [6].
Various features of PRRSV infection and the ensuing immune
response suggest that PRRSV immunity is aberrant. The acute,
viremic infection lasts for 4 to 6 weeks and is followed by a period
of persistent viral proliferation in lymphoid tissues that lasts for
several months before complete resolution of infection [7].
PRRSV infection can induce significant and specific antibody
and B-cell responses to a variety of PRRSV protein [8,9].
Fcc receptor (FccR)-mediated entry of infectious PRRSV
immune complexes into macrophages is hypothesized to be a
key event in the pathogenesis of the disease [10–12]. Infection of
alveolar macrophages by PRRSV is significantly enhanced in vitro
in the presence of diluted anti-PRRSV antisera [10], and the mean
level and duration of viremia are greater in pigs injected with sub-
neutralizing antibodies prior to virus challenge than in pigs
injected with normal IgG [10,12]. The prolonged duration of
viremia and virus isolation from the tissues of piglets with low
maternal antibodies also suggest antibody-dependent enhance-
ment (ADE) of PRRSV [13]. These observations strongly suggest
that ADE of PRRSV infection has the potential to enhance the
severity of disease and possibly the susceptibility to PRRSV
infection in pigs with declining levels of PRRSV-specific antibodies
of maternal origin, or with antibodies induced by exposure to wild-
type or vaccine strains of PRRSV.
IgG Fc Receptors (FccRs) comprise a multigene family of
integral membrane glycoprotein that exhibit complex activation or
inhibitory effects on cell functions after aggregation by complexed
IgG. Four different classes of FccRs, known as FccRI (CD64),
FccRII (CD32), FccRIII (CD16) and FccRIV, have been
extensively characterized in mice and humans [14]. Both FccRI
and FccRIIa have previously been shown to facilitate antibody-
mediated dengue virus enhancement in human macrophage
[15,16], and FccRIIa appeared to be the most effective [17].
FccRII is a 40-kDa molecule detected on monocytes, neutrophils,
eosinophils, platelets and B cells. It has a low affinity for
monomeric IgG, preferentially binding multivalent IgG. Porcine
FccRII, previously characterized by our research group, amino
acid sequence shows a high similarity to human and mouse
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conserved immunoreceptor tyrosine-based inhibitory motif
(ITIM), the swine receptor may also have a similar inhibitory
function [18]. Therefore, it is important to elucidate the role of
porcine FccRIIb in PRRSV infections in order to better
understand PRRSV-porcine cell interactions and the pathogenesis
of PRRSV infections.
Results
Establishment of stable Marc-145 cell lines expressing
poFccRII (Marc-poFccRII)
Marc-145 cell line was selected for transfection with poFccRII,
because it is a permissive cell for PRRSV infection. Three Marc-
145 cell lines stably expressing the poFccRII were established
(data not shown), and one of the cell lines, Marc-poFccRII/1 was
selected for further studies. The expression of poFccRII was
verified by flow cytometry and RT-PCR (Fig. 1A and B).
Expression of poFccRII was stable for as long as 20 continuous
passages, over a period of 2 months.
Efficiency of PRRSV replication and progeny virus
production in Marc-poFccRII
Virus infection and virion production were quantified in the
absence ofPRRSV antibodyusingbothMarc-poFccRIIand parent
Marc-145 cells (Fig. 2). The growth kinetics of PRRSV BJ-4 was
similar in the two cell lines. The results indicate that the infection,
efficiency of PRRSV replication and mature virion production in
Marc-poFccRII was similar to that of the parent cell line.
Augmentation of progeny virus production in Marc-
poFccRII cell line by anti-PRRSV antibody
PRRSV-specific antibody were detected by IDEXX commer-
cial ELISA kit and neutralizing antibody test was performed using
Marc-145 cells. The sera from one pig with the S/P ratio of 1.2
and the sera neutralizing antibody titer of 1/5.9 were used in the
ADE test. Marc-poFccRII cells were infected with PRRSV BJ-4
strain in the presence or absence of serially diluted anti-PRRSV
sera and the virus yield was examined 48 h later. Marc-poFccRII
cells which were infected with PRRSV in the presence of 1/2
4 to
1/2
10 dilutions of anti-PRRSV sera produced a significantly
higher percentage of virus than those infected in the normal
porcine sera (Fig. 3). The anti-PRRSV serum enhanced infection
was optimum at a dilution of 1/128. Normal porcine serum, which
does not contain anti-PRRSV antibodies did not enhance
infection at any dilutions ranging from 1/2 to 1/2
10. These
results suggest that infection with virus-antibody complex results in
viral production.
Analysis of PRRSV-ADE infection in susceptible cells
bearing poFccRII
In order to test whether this enhancement infection specifically
applied to poFccRII positive cells, we pre-incubated PRRSV BJ-4
virions with whole or F(ab’)2 fragment of anti-PRRSV IgG at
80 mg/ml and then added the opsonised virions to either Marc-
poFccRII cell lines, porcine alveolar macrophages (PAMs) or
Marc-145 cells. Anti-PRRSV IgG enhanced the PRRSV infection
in both FcR-bearing cells, Marc-poFccRII cell line and PAMs
(Table 1). No enhancement was seen in the normal Marc-145 cells
Figure 1. Binding of porcine IgG to poFccRII on Marc-poFccRII cells was monitored by flow cytometry. (A). Heat-aggregated IgG was
applied to Marc-poFccRII cells (I–V: passage 1, 5, 10, 15 and 20), followed by washing and incubation with the FITC-conjugated goat anti-porcine IgG.
Open graph shows untransfected wild-type Marc-145 cells; Expression of poFccRII on Marc-poFccRII cells was determined by RT-PCR (B). Total mRNA
was prepared and cDNA was synthesized. This cDNA was then used as a template in polymerase chain reaction (PCR) with poFccRII or porcine
glyceraldehydes 3-phosphate dehydrogenase (GAPDH) specific primers. (lane I–V: passage 1, 5, 10, 15 and 20, lane WT: parent wild-type Marc-145,
and lane M: Macrophages).
doi:10.1371/journal.pone.0028721.g001
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pig IgG had any effect on any cell line (Table 1). Thus, the
enhancement of PRRSV infection appears to be due to the
presence of poFccRII.
Inhibition of anti-PRRSV virus antibody-mediated
infection by anti-poFccRII polyclonal antibodies
Rabbit anti-poFccRII polyclonal antibodies, which are known
to inhibit the binding of porcine IgG to poFccRII, was used to
prove that enhancement of PRRSV infection by anti-PRRSV is
FccRII-mediated [19]. The sera were heat inactivated (56uC for
30 min) to remove intrinsic complement activity. Marc-poFccRII
cells and PAMs were incubated with anti-poFccRII polyclonal
antibodies and were then infected with PRRSV in the presence or
absence of anti-PRRSV antibody. Anti-poFccRII antibody
inhibited the enhancement of infection when cells were infected
in the presence of anti-PRRSV antibody, but not when cells were
infected in the absence of antibody (Fig. 4A and B). Control rabbit
serum did not inhibit infection in the presence or absence of anti-
PRRSV virus antibody (data not shown). These results indicate
that the observed enhancement of infection in the presence of anti-
PRRSV virus antibody is FccRII-mediated.
The infection rates of PRRSV-ADE infection in Marc-
poFccRII cell lines
PRRSV infectivity in Marc-poFccRII cells under the conditions
of ADE infection and control infection was compared at 12, 24
and 48 h post-infection. At 12 h post-infection, there was
increased infectivity for ADE-treated cells, but this finding was
not statistically significant compared with the control (p=0.096).
As the data shown, a clear and significant increase in infectivity
was found after 24 h, with higher numbers of infected cells under
ADE infection conditions (Table 2). Therefore the initial PRRSV
infectivity was not different between ADE and non-ADE infection
in Marc-poFccRII cell lines, suggesting that post-entry intracel-
lular activities are of greater importance.
Discussion
The basis for vaccine development against a wide range of
infective agents is the development of protective antibodies.
However, the discovery of the phenomena of ADE in the 1960s
gave rise to the concern that the development of antibodies could,
at times, exacerbate the reaction to a natural infection. Pigs
infected with PRRSV develop a strong and rapid humoral
response, but the protective effectiveness of these antibodies might
be reduced by ADE. The development of significant levels of no-
Figure 2. Comparison of PRRSV growth kinetics in Marc-145
and Marc-poFccRII cells. Marc-145 and Marc-poFccRII cells were
infected with PRRSV BJ-4 strain and harvested at 24, 48 and 72 h post-
infection and the virus titers were determined by IFA on Marc-145 cells,
respectively. Error bars represented standard errors of mean values from
three experiments.
doi:10.1371/journal.pone.0028721.g002
Figure 3. Antibody-dependent enhancement of PRRSV infection revealed by the increase in viral yield as determined by the
standard ADE assay. Marc-poFccRII cells were exposed to PRRSV-antibody complex, prepared by mixing each dilution of the serum sets with an
equal volume of DMEM media containing PRRSV BJ-4 strain. Production of infectious progeny PRRSV was quantitated by virus titration. Error bars
represented standard errors of mean values from three experiments.
doi:10.1371/journal.pone.0028721.g003
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with anti-poFccRII polyclonal antibodies and were then infected with PRRSV in the presence or absence of anti-PRRSV antibody. Production of
infectious progeny PRRSV was quantified by virus titration. Error bars represented standard errors of mean values from three experiments.
doi:10.1371/journal.pone.0028721.g004
Table 2. Comparison of percent of PRRSV infectivity in Marc-
poFccRII cells at 12–48 h post-ADE or control infection.
Marc-poFccRII
Treatment Percent of infectivity (%)
12 24 48
PRRSV-ADE 0.3060.03 3.6060.15
A 10.3060.32
A
PRRSV-NMS 0.2260.02 1.2360.04
B 3.5060.20
B
The infection rates following treatment with PRRSV-specific antibody was
determined by immunofluorescence microscopy. Within the same column,
mean infectivity (6standard error) with different superscripts differ significantly
(p,0.05).
doi:10.1371/journal.pone.0028721.t002
Table 1. Analysis of PRRSV-ADE infection in poFccRII bearing
cell lines.
Group Progeny virus titer (TCID50/0.1 ml log10)
Anti-PRRSV IgG Anti-PRRSV F(ab’)2 Normal IgG
Marc-poFccRII 4.6160.16
A 3.9160.13
B 4.060.13
B
Marc-145 3.9760.12 3.7060.05 3.8860.07
Macrophages 4.7960.07
A 3.8560.05
B 3.8060.08
B
PRRSV BJ-4 virions with whole or F(ab’)2 fragment of anti-PRRSV IgG were
added to either Marc-poFccRII cell lines and macrophages or Marc-145 cells.
Anti-PRRSV sera enhanced the PRRSV infection in FcR-bearing cells of Marc-
poFccRII cell lines and macrophages infection. Data are shown as mean of three
independent experiments. Within the line, means (6standard error) with
different superscripts differ significantly (p,0.01).
doi:10.1371/journal.pone.0028721.t001
Porcine FccRIIb Mediates ADE
PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e28721neutralizing antibodies especially early may actually mediate ADE
[20].
Antibody-FccR interaction is known to play a key role in ADE
phenomenon. The FccR-mediated mechanism of ADE in virus
infections was first suggested by Halstead et al. who reported that
F(ab’)2 fragments prepared from IgG did not enhance infection in
peripheral blood leukocyte cultures by dengue virus (DV) while
whole IgG did [21]. To date, four different classes of FccRs,
known as FccRI, FccRII, FccRIII and FccRIV, have been
recognized in mice. FccRI (CD64) is a high affinity receptor found
mainly on myelomonocytic cells, that can bind to monomeric IgG,
whereas FccRII (CD32) and FccRIII (CD16) are of lower affinity,
binding primarily aggregated IgG or IgG in immune complexes
[22], and FccRIV is a recently identified receptor of intermediate
affinity and restricted subclass specificity [23]. Kontny et al.
showed that FccRI mediated ADE of DV infection in U937 cells
[15]. In a related study, FccRIIa was also reported to mediate
ADE of DV infection in a human erythroleukemic cell line (K562),
which has only FccRIIa [16]. In the present paper, we have shown
that porcine FccRIIb will mediate ADE of PRRSV infection. The
relative viral yield was significantly increased in the presence of
sub-neutralizing levels of anti-PRRSV antibody in stable Marc-
145 cell lines expressing poFccRIIb (Marc-poFccRII) (Fig. 3). The
enhancement was not evident for Marc-145 cells not bearing
FccRs. The Fab fragment and the normal porcine sera had no
effect (Table 1). Thus, the enhancement of PRRSV load was due
to poFccRII.
Unlike the previously identified FccRI and FccRIIa mediating
ADE of virus infection, poFccRIIb is an inhibitory FccR that can
prevent activation of immune cells by recruitment of SHIP (Src
Homology 2-containing 59-inositol phosphatase) to its cytoplasmic
ITIM (immunoreceptor tyrosine-based inhibition motif) [18].
During initial studies on ADE it had been assumed that increased
virus output resulted from the avid attachment of opsonised virus
to FccRI and FccIIa receptors, therefore yielding a larger number
of infected cells [24,25]. An alternative proposal was that infection
via Fc and FcR ligation also alters the intracellular signaling
pathways, resulting in their switching from an anti-viral mode to a
viral-facilitating mode. This process has been termed intrinsic
antibody-dependent enhancement (iADE) [26,27]. Infection under
conditions of iADE may not only facilitate the process of viral
entry into macrophages but also modify the innate and adaptive
intracellular antiviral mechanisms. The innate immune response
suppression involves a decreased production of reactive nitrogen
radicals via nitric oxide synthase (NOS2) suppression and down-
regulation of tumor necrosis factor alpha (TNF-a) and IFN-b
production through abolished interferon regulatory factor 1 (IRF-
1) and NF-kB gene expression, while a marked increase in IL-10
gene transcription and protein production is also observed [28,29].
In the present work, the infection rate between poFccRII-
mediated ADE infection was compared, and the initial PRRSV
infectivity was not different between ADE and non-ADE infection
in Marc-poFccRII cell lines, suggesting that iADE behaviour is of
great importance in PRRSV infection (Table 2). The intracellular
mechanisms and implications of enhanced pathogenesis of iADE
may be the result of the inhibitory signals after interactions of
infectious immune complexes with FccRIIb, the inhibitory Fc
receptor. The mechanisms of the inhibitory signal of the FccRIIb
receptor in regulating the viral replication and production need
further investigation.
Antibody-dependent enhancement of virus infection is a
significant obstacle to the development of effective vaccines for
the control of certain human and animal viral diseases. The ADE
in PRRSV infection has been suspected as one of the possible
reasons for the relative ineffectiveness of vaccination in controlling
PRRS. In the present paper we have shown that poFccRIIb, an
inhibitory FccR can mediate ADE of PRRSV infection, as does
FccRI and FccRIIa, the activation FccRs, in the DENV.
Identification of the inhibitory FccR involvement in the ADE
process expands our understanding of the mechanisms of
pathogenesis for a broad range of infectious diseases and opens
approaches for improvement in the treatment and prevention of
such diseases. The new ADE assay using Marc-poFccRII cells is
simple and practical, and is useful for defining the role of ADE in
the pathogenesis of PRRSV infection.
Materials and Methods
Cells, virus and antibodies
Marc-145 cells were used for virus titration and maintained in
Dulbecco’s modified Eagle’s minimal essential medium (Gibco)
supplemented with 10% (v/v) fetal bovine serum (FBS, Life
Technologies). The PAMs were collected from 4 to 6 week old
piglets free of PRRSV, by lung lavage as previously described
(Zhang et al., 2006). PAMs were dispensed at 1610
5 cells/well
into 24-well plate and maintained in RPMI-1640 (Gibco)
supplemented with 10% FBS containing an antibiotic-antimycotic
mixture of 100 mg/ml streptomycin, 100 IU/ml penicillin and
25 mg/ml amphotericin B (Sigma) and incubated at 37uCi na
humidified atmosphere containing 5% CO2.
The PRRSV strain BJ-4 was a typical North American
(VR2332)-like PRRSV isolated in 1996 in China and its complete
genomic sequence has been determined and deposited in
GenBank (accession no. AF331831). The virus was supplied by
Dr. Hanchun Yang of China Agricultural University. Anti-
PRRSV sera were obtained from 3 pigs 50 days following nasal
inoculation with 10
4 TCID50 of the PRRSV BJ-4 strain. Control
sera were obtained from PRRSV antibody-free pigs of similar age.
F(ab’)2 fragments were generated by pepsin digestion of isolated
IgG and then depleted of undigested antibody and Fc fragments
by passage over a protein A-sepharose column. The PRRSV-
specific antibody titers were determined by using the commercially
available PRRSV antibody detection kit (HerdCheck PRRS;
IDEXX) according to the manufacturer’s instructions. The virus
neutralization (VN) antibody titer was determined in 96-well
microtitration plates using Marc-145 cells. Serum samples were
heat inactivated at 56uC for 30 min prior to performing the test
and serially diluted 2-fold. Each dilution of serum was mixed with
an equal volume of PRRSV BJ-4 strain containing 2610
2
TCID50/ml and incubated for 1 h at 37uC. The serum-virus
mixture was transferred to a 96-well plate containing confluent
Marc-145 cells, and the cells were analyzed for CPE at 5 days post
inoculation. The VN antibody titer was defined as the reciprocal
of the highest dilution that inhibited CPE in 50% of the inoculated
wells.
The experimental procedure for the collection of porcine
alveolar macrophages was authorized and supervised by the
Ethical and Animal Welfare Committee of Key Laboratory of
Animal Immunology of the Ministry of Agriculture of China.
Stable expression of poFccRII on Marc-145 cells
The recombinant eukaryotic cell expression vector of pcDNA3-
poFccRII was constructed as previously described [18]. Marc-145
cells were transfected with BgIII-linearized poFccRII cDNA
constructs using Lipofectamine 2000 (Invitrogen) according to
the manufacturers’ protocols. Transfected cells were selected with
500 mg/ml G418 (Invitrogen) for two weeks and then further
selected by the limiting dilution method. The G418-resistant
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described previously [18]. The surface expression of poFccRII
was verified by the binding of porcine aggregated-IgG and
assessed by flow cytometry.
IgG-binding assay
Surface expression of poFccRII was examined by IgG-binding
assay on stably transfected Marc-145 cells as described previously
[19]. Porcine IgG was aggregated at 62uC for 20 min. Aggregated
IgG was added to the transfected cells. Cells were incubated with
the FITC-conjugated goat anti-porcine IgG for 30 min at 4uC,
then pelleted and washed twice with PBS. Fluorescent spectra
were analyzed by a BD FACSCalibur flow cytometer counting
10,000 cells per sample.
Infection of cells with PRRSV and PRRSV-antibody
complex
Infection of cells with PRRSV-antibody complex was conducted
as previously described [10]. BJ-4-specific antibody-positive and
antibody-free serums were de-complemented by heat-inactivation
at 56uC for 45 min and serially diluted 2-fold from 2
1 to 2
10 in
DMEM growth media. PRRSV-antibody complex was prepared
by mixing each dilution of the serum sets with an equal volume of
DMEM media containing 10
4.5 TCID50/ml of PRRSV BJ-4
strain. Virus-antibody mixtures were incubated for 60 min at
37uC. One-tenth of a milliliter of virus-antibody mixture was
inoculated in triplicate onto cell monolayers in 24-well cell culture
plates. The plates were incubated at 37uC for 60 min. After virus
absorption, cells were washed with 1 ml of DMEM and overlaid
with maintenance medium with 2% FCS for an additional 48 h at
37uC. At the end of the incubation period, the cells were subjected
to 3 cycles of freeze-thawing. The amount of PRRSV in each cell
lysate was quantitated by virus titration as described [10]. Virus
titers were determined by the method of Reed and Muench and
expressed as TCID50/0.1 ml.
The infection rates following treatment with PRRSV-specific
antibody was determined by immunofluorescence microscopy.
Cells infected as above and incubated for 48 h were fixed in cold
methanol for 10 min. After washing the cells were incubated for
2 h at 37uC with a monoclonal antibody, 2D6, specific for the
nucleocapsid protein of PRRSV (VMRD), followed by the
addition of FITC-conjugated sheep anti-mouse IgG antibodies
(Sigma) for 1 h at 37uC, after which the cells were counted using a
fluorescence microscope. Between antibody incubation and prior
to viewing under the microscope, the cells were washed three times
with sterile PBS. Ten fields were counted, and mean infectivity
(6SE) was calculated.
Statistical analysis
Data were subjected to one-way analysis of variance (one-way
ANOVA). If the P value from the ANOVA was less than or equal
to 0.05, pairwise comparisons of the different treatment groups
were performed by a least-significant difference test at a rejection
level of a P value,0.05.
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